LeMaitre Vascular, Inc.

LMAT Healthcare Medical Instruments & Supplies

LeMaitre Vascular, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $249.6 million, up 13.5% from fiscal 2024. In the quarter to June 2026, revenue grew 9.57%, EPS grew 23.0%, free cash flow fell 28.0% and total debt was flat, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.

80.82 2.34 −2.81%
Market cap
$1.9B
P/E
27.9×
Fwd P/E
31.5×
Dividend yield
1.18%
F-score
6/9
Altman Z
6.99
Beneish M
−2.61
Dividend safety
93/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

5 6 6 7
ROE
15.02% 15.80% 16.55% 16.77%
ROA
10.94% 9.89% 10.53% 10.78%
ROIC
18.95% 20.90% 21.93% 22.67%
Return on Tangible Assets
11.98% 12.58% 13.19% 13.46%
Average Days of Receivables
49.12 49.15 50.94 49.63
Free Cash Flow per Share
2.92 3.29 3.47 3.23
Free Cash Flow
66.23 74.47 79.12 73.83
Other line items

Show all line items

Columns are period end dates